| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric serves as a President &Immunovant CEO at ROIV. Across recent SEC filings that breaks down to 0 buys and 85 sells. Those positions are worth an estimated $58.4M at current prices.
Historically, Venker Eric's trades have earned a below-average insider score of 42/100 across 81 rated trades. Over a 12-month horizon, 16.1% of those trades were profitable, with an average 12-month return of -44.5%.
The biggest single holding is ROIV (~$58.4M) as President &Immunovant CEO. The recent filings there lean toward selling, a net 12,977,626 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 59,811 | $11.89 | $711,152.79 | -8.7% | -22.7% | -3.0% | |
| Aug 3, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 44,629 | $11.93 | $532,423.97 | -6.6% | -21.2% | -8.6% | |
| Aug 2, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 195,166 | $11.91 | $2,324,221.18 | -9.4% | -26.8% | -10.1% | |
| Jul 27, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 125,534 | $10.91 | $1,369,812.28 | -6.2% | -20.9% | 0.0% | |
| Jul 24, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 374,466 | $11.19 | $4,189,880.04 | -16.2% | -19.9% | +2.6% | |
| Jun 9, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 299,585 | $9.91 | $2,968,875.29 | -18.5% | +16.7% | +4.4% | |
| May 23, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 415 | $9.85 | $4,087.75 | - | +16.7% | +20.2% | |
| May 9, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 238,724 | $9.23 | $2,203,422.52 | -26.1% | +20.0% | +19.6% | |
| May 8, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 150,044 | $8.56 | $1,283,924.98 | -10.0% | +25.4% | +27.0% | |
| May 3, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 288,989 | $8.40 | $2,427,128.91 | -12.5% | +41.4% | +33.2% |